- Home
- TLSI vs DSP Comparison
TLSI vs DSP Comparison
Compare TLSI & DSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TLSI | DSP |
|---|---|---|
| Founded | 2010 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 244.3M | 198.1M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | TLSI | DSP |
|---|---|---|
| Price | $6.89 | $11.93 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | $11.50 | ★ $18.50 |
| AVG Volume (30 Days) | ★ 232.5K | 229.2K |
| Earning Date | 11-13-2025 | 11-10-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 29.49 |
| EPS | N/A | ★ 0.10 |
| Revenue | $40,207,000.00 | ★ $324,131,000.00 |
| Revenue This Year | $55.06 | $17.79 |
| Revenue Next Year | $46.04 | $17.72 |
| P/E Ratio | ★ N/A | $121.66 |
| Revenue Growth | ★ 49.52 | 22.97 |
| 52 Week Low | $3.42 | $8.11 |
| 52 Week High | $7.95 | $26.33 |
Technical Indicators
Market Signals| Indicator | TLSI | DSP |
|---|---|---|
| Relative Strength Index (RSI) | 54.55 | 63.23 |
| Support Level | $6.80 | $11.54 |
| Resistance Level | $7.95 | $12.15 |
| Average True Range (ATR) | 0.46 | 0.49 |
| MACD | -0.11 | -0.05 |
| Stochastic Oscillator | 14.06 | 60.47 |
Price Performance
Historical ComparisonAbout TLSI TriSalus Life Sciences Inc.
TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.
About DSP Viant Technology Inc.
Viant Technology Inc is an advertising software company. The software enables the programmatic purchase of advertising, which is the electronification of the advertising buying process. It operates a cloud-based demand side platform ("DSP") that is used by marketers and its advertising agencies to centralize the planning, buying and measurement of its advertising across channels, including connected TV (CTV), streaming audio, digital out-of-home, mobile and desktop.